Black Rock Inc. Mersana Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 8,383,910 shares of MRSN stock, worth $230 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,383,910

Previous 8,095,729 3.56%

Holding current value

$230 Million

Previous $36.3 Million 53.54%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.0 - $4.45 $576,362 - $1.28 Million	288,181 Added 3.56%	8,383,910 $16.9 Million
Q1 2024 May 10, 2024	BUY	$2.16 - $5.94 $543,125 - $1.49 Million	251,447 Added 3.21%	8,095,729 $36.3 Million
Q4 2023 Feb 13, 2024	SELL	$1.11 - $2.34 $142,499 - $300,404	-128,378 Reduced 1.61%	7,844,282 $18.2 Million
Q3 2023 Nov 13, 2023	BUY	$1.06 - $3.91 $9,198 - $33,930	8,678 Added 0.11%	7,972,660 $10.1 Million
Q2 2023 Aug 11, 2023	BUY	$3.08 - $9.55 $1.51 Million - $4.68 Million	490,160 Added 6.56%	7,963,982 $26.2 Million

Q1 2023 May 12, 2023	SELL	$4.0 - $7.02 $72,428 - $127,111	-18,107 Reduced 0.24%	7,473,822 $30.7 Million
Q4 2022 Feb 13, 2023	BUY	$5.65 - $7.86 $2.28 Million - $3.17 Million	403,842 Added 5.7%	7,491,929 $43.9 Million
Q3 2022 Nov 14, 2022	SELL	$4.63 - $8.0 $8.3 Million - $14.3 Million	-1,792,932 Reduced 20.19%	7,088,087 $47.9 Million
Q2 2022 Aug 12, 2022	BUY	$2.84 - $5.0 $3.56 Million - $6.27 Million	1,254,823 Added 16.45%	8,881,019 $41 Million
Q1 2022 May 12, 2022	BUY	$3.74 - $6.63 $549,656 - $974,391	146,967 Added 1.97%	7,626,196 $30.4 Million
Q4 2021 Feb 10, 2022	SELL	$5.48 - $9.86 $7.28 Million - $13.1 Million	-1,328,099 Reduced 15.08%	7,479,229 $46.5 Million
Q3 2021 Nov 09, 2021	SELL	$8.56 - $14.47 $131,618 - $222,490	-15,376 Reduced 0.17%	8,807,328 $83.1 Million
Q2 2021 Aug 11, 2021	BUY	$13.28 - $18.07 $117 Million - $159 Million	8,822,704 New	8,822,704 $120 Million

Others Institutions Holding MRSN

# of Institutions

Shares Held

22.2M

Call Options Held

Put Options Held

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $2.67B
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account